SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)

Clinical and Translational Oncology

Volumn 11, Issue 5, 2009, Pages 284-289

  Felip, Enriqueta ^a   Garrido, Pilar ^b   Trigo, José Manuel ^c   López Brea, Marta ^d   Paz Ares, Luis ^e   Provencio, Mariano ^f   Isla, Dolores ^g  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^g HOSPITAL CLÍNICO UNIVERSITARIO LOZANO BLESA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; CISPLATIN; FLUORODEOXYGLUCOSE; GEMCITABINE; NAVELBINE; PEMETREXED; TAXANE DERIVATIVE;

CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; SHORT SURVEY; WHOLE BODY TOMOGRAPHY; ARTICLE; FEMALE; INCIDENCE; LUNG TUMOR; MALE; PATHOLOGY;

CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING;

EID: 68849113675     PISSN: 1699048X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12094-009-0356-4     Document Type: Short Survey

References (13)

1. A. Jemal R. Siegel E. Ward, et al. 2007 Cancer statistics CA Cancer J Clin 57 43 66 17237035 10.3322/canjclin.57.1.43
2. P. De Leyn D. Lardinois P. Van Schil, et al. 2007 European trends in preoperative and intraoperative staging: ETS guidelines J Thorac Oncol 2 357 361 17409811 10.1097/01.JTO.0000283187.24297.f7
3. C.F. Mountain 1997 Revisions in the International System for Staging Lung Cancer Chest 111 1710 1717 9187198 10.1378/chest.111.6.1710 1:STN:280:DyaK2szjtVOguw%3D%3D
4. P. Goldstraw J. Crowley K. Chansky, et al. 2007 The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours J Thorac Oncol 2 706 714 17762336 10.1097/JTO.0b013e31812f3c1a (Pubitemid 47357522)
5. J.Y. Douillard R. Rosell M. De Lena, et al. 2006 Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial Lancet Oncol 7 719 727 16945766 10.1016/S1470-2045(06)70804-X 1:CAS:528:DC%2BD28Xptlyku7c%3D (Pubitemid 44283661)
6. J.P. Pignon H. Tribodet G.V. Scagliotti, et al. 2008 Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group J Clin Oncol 26 3552 3559 18506026 10.1200/JCO.2007.13.9030
7. R. Rosell J. Gomez Codina C. Camps, et al. 1994 A randomized trial comparing preoperative chemotherapy plus surgery with surgery alone in patients with non-small cell lung cancer N Engl J Med 330 153 158 8043059 10.1056/NEJM199401203300301 1:STN:280:DyaK2c%2FovVKrsA%3D%3D (Pubitemid 24026882)
8. K. Albain S. Swan V. Rush, et al. 2005 Phase III study of concurrent chemotherapy and radiotherapy versus chemotherapy and radiotherapy followed by surgical resection for stage IIIA (pN2) non-small cell lung cancer: outcome updates of North America Intergroup 0139 Proc Am Soc Clin Oncol 23 624s
9. N. Hanna M. Neubauer C. Yiannoutsos, et al. 2008 Phase III study of cisplatin, etoposide, and concurrent chest radiation with or without consolidation docetaxel in patients with inoperable stage III non-small-cell lung cancer: the Hoosier Oncology Group and U.S. Oncology J Clin Oncol 26 5755 5760 19001323 10.1200/JCO.2008.17.7840 1:CAS:528:DC%2BD1MXotFemug%3D%3D
10. E. Vokes J. Herdorn M. Kelley, et al. 2007 Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III non-small cell lung cancer: Cancer and Leukemia Group B J Clin Oncol 25 1698 1704 17404369 10.1200/JCO.2006.07.3569 1:CAS:528:DC%2BD2sXlvFyktb0%3D (Pubitemid 46797950)
11. G. D'Addario E. Felip 2008 Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up Ann Oncol 19 [Suppl2] ii39 ii40 18456762 10.1093/annonc/mdn081
12. A.B. Sandler R. Gray M.C. Perry, et al. 2006 Paclitaxel-carboplatin alone or with bevacizumab for non-small cell lung cancer N Engl J Med 355 2542 2550 17167137 10.1056/NEJMoa061884 1:CAS:528:DC%2BD28XhtlWqsbzI (Pubitemid 44917502)
13. G.V. Scagliotti P. Parikh J. von Pawel, et al. 2008 Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage NSCLC J Clin Oncol 26 3543 3551 18506025 10.1200/JCO.2007.15.0375 1:CAS:528:DC%2BD1cXpvVWmtLg%3D